Blog

Immunotoxicity Studies for Early Drug Discovery

The immune system is the body's mechanism of defense against harmful pathogens such as bacteria, viruses, and fungi, to abnormal cells and plays an.

read more

What is mCherry and How is it used?

mCherry is a fluorescent protein that presents a monomeric structure of 236 amino acids and a mass of 26.7 kDa. Fluorescent proteins are members of a.

read more

Polyester Toxicity Study: How to Test for Toxicities

Exposure to certain chemicals and harmful substances, such as polyester or metals in textile products can cause a genetic change in cells which can.

read more

Ex Vivo vs In Vitro: Understand the Difference

Numerous experimental models currently used in the preclinical arena can aid the research and development of new pharmaceutical compounds and Drug.

read more

The Drug Discovery Process: What Is It and Its Major Steps

As science advances, Drug Discovery aims to keep fueling new medicines to cure and palliate many ailments and some untreatable diseases that still.

read more

In Silico for Drug Discovery

The in silico method represents an increasing role in drug discovery as technology becomes more sophisticated. It is fast becoming a cost-effective.

read more

Benefits of Animal Testing: How Ethical Testing Aids Research

Animal testing has had an influential role in almost every medical breakthrough in the last 100 years. Further, animals are essential in assessing.

read more

OECD guidelines for Chronic Toxicity studies

Chronic Toxicity studies are a form of assays that are likely to affect the health of a subject if exposed to a substance repeatedly or constantly.

read more

PDX and Oncology avatars in Zebrafish

Cancer is a devastating and complex disease, generated by an alteration in the cells, caused by genetic and epigenetic alterations that produce a.

read more

ALS Assessment in Zebrafish

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. These neurons.

read more